- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nano Chemical Systems Holdings, Inc. (NanoChem or "The Company") (OTC Bulletin Board: NCSH)
announced today that it has completed a full operational assessment in conjunction with Pangea Ultima, which is the principal privately held investment firm supporting NanoChem. As a result, it was concluded that the current NanoChem manufacturing assets allow the Company to produce and ship
product with a revenue value that can exceed $150,000,000 per year.
In the categories that NanoChem competes, plant manufacturing usages average 84 percent of capacity. For calendar year 2006, NanoChem operated their plant at less than 5 percent of their existing capacity. Dr. Mathew Zuckerman, NanoChem's CEO and President stated, "Our near term goal is to augment the existing NanoChem organization with sufficient marketing and sales resources that will allow the Company to ship product with at an annualized sales rate value of $45,000,000 in 2007. That objective is meaningful in that it is a through put level of 35 percent, which in turn increases NanoChem's gross margins to over 55 percent."
The remaining plant capacity will be used for value added opportunity sales that exceed the $45,000,000 objective and to further develop the company's proprietary Nano-enhanced products that include but are not limited to; oils, waxes and photochemical products.
Dr. Zuckerman when on to say that he expects that in 2007, NanoChem will realize value well beyond that of a profitable consumer products company, as various licensing agreements and joint ventures are concluded to begin the roll out of new, intellectually protected products.
"Given the dynamic manufacturing, intellectual and patent protected assets that exist at NanoChem, we are rapidly becoming a new age consumer products company that combines traditional manufacturing techniques with in-demand, highly technical and revolutionary products," stated Dr. Zuckerman.
About Nano Chemical Systems Holdings, Inc.
Nano Chemical Systems Holdings, Inc. has a wholly owned subsidiary, SeaSpray Aerosol, Inc. that produces aerosol products for its own formula and does private labeling for various customers. SeaSpray operates out of a 36,000 square foot facility that contains offices, research, warehouse and manufacturing operations. The Company is also engaged in enhancing the effectiveness of its product line using nanotechnology where applicable.
Forward Looking Statements
Certain statements in this release and other written or oral statements made by or on behalf of the Company are "forward looking statements" within the meaning of the federal securities laws. Statements regarding future events and developments and our future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. The forward looking statements are subject to a number of risks and uncertainties including market acceptance of the Company's services and projects and the Company's continued access to capital and other risks and uncertainties outlined in its filings with the Securities and Exchange Commission, which are incorporated herein by reference. The actual results the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. These statements are based on our current expectations and speak only as of the date of such statements. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of future events, new information or otherwise.
For more information, please click here
INVESTOR CONTACT: Redwood Consultants, LLC 415-884-0348
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Arrowhead to Report Fiscal 2015 First Quarter Financial Results February 2nd, 2015
Graphenea sales more than double in 2014 January 29th, 2015
To Conserve London's 300-Year-Old Masterpiece, Nanotech & Drones April 12th, 2015
2015 Nanonics Image Contest January 29th, 2015
OCSiAl supports NanoART Imagery Contest January 23rd, 2015